Acquisition-Related Amortization and Remeasurement - Additional Information (Details) - License Agreement [Member] - USD ($) $ in Millions		1 Months Ended
	Dec. 29, 2022	May 31, 2022	Apr. 30, 2021	Dec. 31, 2023	Dec. 31, 2022
Research And Development Arrangement Contract To Perform For Others [Line Items]
Consideration agreed to pay with additional payments contingent upon reaching future commercialization and revenue-based milestones	$ 0.2
Initial payment accrued					$ 0.2
Contingent Payment Upon Reaching FDA Milestone			$ 4.0
Amount Received for the year		$ 1.5	$ 0.5
Contingent consideration milestone obligation		$ 3.5
Other Current Liabilities [Member]
Research And Development Arrangement Contract To Perform For Others [Line Items]
Contingent consideration accrued				$ 1.0	$ 1.0